慢性血栓栓塞性肺高血压的发病,诊断和管理
Malika Elhage Hassan1, Jorge Vinales2, Sidney Perkins3
1Division of Cardiology, Department of Medicine, Emory University School of Medicine, 1364 Clifton Road Northeast Suite F606, Atlanta, GA 30322, USA.
Interventional cardiology clinics
|July 4, 2024
概括
慢性血栓栓塞性肺高血压 (CTEPH) 是由肺血管中的血块引起的. 诊断往往会延迟,但手术和药物治疗等治疗方法为管理这种复杂的疾病提供了希望.
科学领域:
- 肺部医学 肺部医学
- 心血管研究研究心血管研究
- 血液学 血液学 血液学
背景情况:
- 慢性血栓栓塞性肺高血压 (CTEPH) 是由肺动脉中未解决的血块引起的严重疾病.
- 它的发展涉及复杂的病理生理学,包括血液凝块分解 (纤维解),血管内膜 (内皮) 功能以及身体对低氧的反应 (低氧适应) 的问题.
- 由于模糊的症状和缺乏常规查,延迟诊断是常见的.
研究的目的:
- 要总结目前对CTEPH病理生理学的理解.
- 概述CTEPH的诊断方法.
- 审查CTEPH的治疗选择.
主要方法:
- 审查关于CTEPH的现有文献.
- 对诊断方式的分析.
- 评估当前和新兴的治疗策略.
主要成果:
- CTEPH的病理生理学是多因素的,涉及纤维素分解,内皮功能障碍和缺氧适应.
- 诊断工具包括V/Q扫描,心声学,心脏导管和肺血管学.
- 肺内关节切除术是唯一可治愈的治疗方法,但40%的患者无法进行手术. 里奥西瓜特是FDA批准的;其他药物正在试验中.
结论:
- CTEPH是一种复杂的疾病,诊断迟到.
- 有效的管理需要诊断工具和治疗干预措施的结合.
- 虽然手术可以治愈,但药理疗法对于无法手术的患者和正在进行的研究至关重要.
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
167
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
167
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
156
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
156
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
COPD: Pathogenesis and Clinical Features
257
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
257


